Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You Tang

Showing results (391-400 of 440) with videos related to

Pageof 44
Sort By:
Zhonghua Yi Xue Za Zhi|June 27, 2006
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]Yi-feng He, Jia Fan, Jian Zhou, et al.
Journal of Cancer Research and Clinical Oncology|March 10, 2010
Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinomaPeng-Yuan Zhuang, Ju-Bo Zhang, Wei Zhang, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2003
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasisShi-Jian Ding, Yan Li, Ye-Xiong Tan, et al.
American Journal of Cancer Research|June 1, 2017
Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinomaCheng-Hao Wang, Xiao-Dong Zhu, De-Ning Ma, et al.
Gastroenterology|January 20, 2009
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell featuresTaro Yamashita, Junfang Ji, Anuradha Budhu, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2009
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinomaXin-Da Zhou, Zhao-You Tang, Jia Fan, et al.
Chinese Medical Journal|May 19, 2005
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, ChinaJian Zhou, Jia Fan, Zhi-quan Wu, et al.
Annals of Surgical Oncology|September 30, 2022
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular CarcinomaXiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
The Oncologist|June 17, 2010
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionJin-Bin Jia, Wen-Quan Wang, Hui-Chuan Sun, et al.
BMC Cancer|January 22, 2011
Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonographyXiao-Dong Zhu, Ju-Bo Zhang, Pei-Li Fan, et al.
Pageof 44

Showing results (391-400 of 440) with videos related to

Sort By:
Pageof 44
Zhonghua Yi Xue Za Zhi|June 27, 2006
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]Yi-feng He, Jia Fan, Jian Zhou, et al.
Journal of Cancer Research and Clinical Oncology|March 10, 2010
Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinomaPeng-Yuan Zhuang, Ju-Bo Zhang, Wei Zhang, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2003
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasisShi-Jian Ding, Yan Li, Ye-Xiong Tan, et al.
American Journal of Cancer Research|June 1, 2017
Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinomaCheng-Hao Wang, Xiao-Dong Zhu, De-Ning Ma, et al.
Gastroenterology|January 20, 2009
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell featuresTaro Yamashita, Junfang Ji, Anuradha Budhu, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2009
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinomaXin-Da Zhou, Zhao-You Tang, Jia Fan, et al.
Chinese Medical Journal|May 19, 2005
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, ChinaJian Zhou, Jia Fan, Zhi-quan Wu, et al.
Annals of Surgical Oncology|September 30, 2022
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular CarcinomaXiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
The Oncologist|June 17, 2010
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionJin-Bin Jia, Wen-Quan Wang, Hui-Chuan Sun, et al.
BMC Cancer|January 22, 2011
Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonographyXiao-Dong Zhu, Ju-Bo Zhang, Pei-Li Fan, et al.
Pageof 44